)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
The 220-key luxury hotel on the Jaipur-Ajmer Highway is part of Manglam Group's broader Rs 1,000 crore hospitality investment plan over five years
Share of national developers in Delhi-NCR's residential supply has risen from 3 per cent in 2022 to over 13 per cent, driven by premium housing demand and infrastructure growth
Centre mandates periodic renewal of registrations for ART and surrogacy clinics to strengthen oversight, improve compliance, and boost patient confidence
The company has also deposited Rs 29.5 crore as security, with the lease including a 4.25 per cent rent escalation every year
Department of Pharmaceuticals invites stakeholder comments on proposed additions and deletions to the list of medical devices exempted from Global Trade Enquiry requirements
Co-working and flex-space provider commits Rs 121 crore over five years for Hyderabad office space as it pursues expansion across key urban and Tier-I markets
Health Ministry prohibits 16 fixed drug combinations, including antibiotic and cosmetic formulations, after an expert review found they lacked therapeutic justification and posed potential health risk
Drug regulator alleges irregularities in reporting adverse events and conflict-of-interest disclosures by the unit's ethics committee during human clinical trials
Experts flag coordination gaps as Centre bets on transit-led satellite hubs
The retailer's India arm has leased 8.3 lakh sq ft at Embassy Manyata Business Park, reinforcing Bengaluru's position as the leading hub for GCC-led office demand
Developer launches Rs 1,100-crore Tulip Melrose project on Southern Peripheral Road as part of a larger luxury housing expansion plan
The removal of cough syrups from Schedule K could make access more prescription-dependent in rural India, potentially shifting some demand towards Ayush products
The acquisition adds to a series of high-value transactions at DLF's super-luxury Gurugram project, where prices have risen sharply since launch
The state regulator has directed hospitals and doctors to provide prescriptions directly to patients and allow them to buy medicines from any licensed pharmacy
The company has launched a generic version of Pfizer's Bosulif for chronic myeloid leukaemia and secured 180 days of exclusivity for the 400 mg strength
NPPA raises ceiling prices of key cancer drugs and select vaccines to address supply shortages and ensure continued availability of essential medicines
Developers brace for up to year-long project delays as the prolonged West Asia conflict raises costs, disrupts supplies and worsens labour shortages
Housing demand remains resilient and project financing is better than in previous cycles, says Anarock
Clears way for higher rates for Cisplatin and Carboplatin amid supply crunch
Vietnamese mobility firm expands workspace footprint as it scales its all-electric taxi service, with plans to add more facilities across the Delhi-NCR region